All 0 3 0 3 O
other 4 9 4 9 O
required 10 18 10 18 O
tests 19 24 19 24 O
to 25 27 25 27 O
assess 28 34 28 34 O
non 35 38 35 38 B-chronic_disease
- 38 39 38 39 I-chronic_disease
measurable 39 49 39 49 I-chronic_disease
disease 50 57 50 57 I-chronic_disease
must 58 62 58 62 O
be 63 65 63 65 O
performed 66 75 66 75 O
within 76 82 76 82 O
42 83 85 83 85 B-upper_bound
days 86 90 86 90 I-upper_bound
prior 91 96 91 96 I-upper_bound
to 97 99 97 99 O
enrollment 100 110 100 110 O

Male 0 4 111 115 B-gender
subjects 5 13 116 124 I-gender
must 14 18 125 129 O
agree 19 24 130 135 O
to 25 27 136 138 O
practice 28 36 139 147 O
contraception 37 50 148 161 B-contraception_consent

Measurable 0 10 162 172 B-chronic_disease
or 11 13 173 175 O
non 14 17 176 179 B-chronic_disease
- 17 18 179 180 I-chronic_disease
measurable 18 28 180 190 I-chronic_disease
disease 29 36 191 198 I-chronic_disease
must 37 41 199 203 O
be 42 44 204 206 O
present 45 52 207 214 O
outside 53 60 215 222 O
the 61 64 223 226 O
previous 65 73 227 235 B-treatment
radiation 74 83 236 245 I-treatment
field 84 89 246 251 I-treatment
or 90 92 252 254 O
a 93 94 255 256 O
new 95 98 257 260 O
lesion 99 105 261 267 O
inside 106 112 268 274 O
the 113 116 275 278 O
radiation 117 126 279 288 B-treatment
port 127 131 289 293 I-treatment
must 132 136 294 298 O
be 137 139 299 301 O
present 140 147 302 309 O

Must 0 4 310 314 O
be 5 7 315 317 O
no 8 10 318 320 O
anticipated 11 22 321 332 O
need 23 27 333 337 O
for 28 31 338 341 O
concurrent 32 42 342 352 O
radiation 43 52 353 362 B-treatment
therapy 53 60 363 370 I-treatment
during 61 67 371 377 O
protocol 68 76 378 386 O
treatment 77 86 387 396 B-treatment

Must 0 4 397 401 O
have 5 9 402 406 O
had 10 13 407 410 O
no 14 16 411 413 O
major 17 22 414 419 B-treatment
surgery 23 30 420 427 I-treatment
within 31 37 428 434 O
28 38 40 435 437 B-upper_bound
days 41 45 438 442 I-upper_bound
prior 46 51 443 448 I-upper_bound
to 52 54 449 451 O
enrollment 55 65 452 462 O

Must 0 4 463 467 O
have 5 9 468 472 O
no 10 12 473 475 O
contraindication 13 29 476 492 O
to 30 32 493 495 O
any 33 36 496 499 O
of 37 39 500 502 O
the 40 43 503 506 O
required 44 52 507 515 O
concomitant 53 64 516 527 O
drugs 65 70 528 533 O
or 71 73 534 536 O
supportive 74 84 537 547 O
treatments 85 95 548 558 B-treatment
, 95 96 558 559 O
including 97 106 560 569 O
hypersensitivity 107 123 570 586 O
to 124 126 587 589 O
all 127 130 590 593 O
anticoagulation 131 146 594 609 B-allergy_name
and 147 150 610 613 O
antiplatelet 151 163 614 626 B-allergy_name
options 164 171 627 634 I-allergy_name
, 171 172 634 635 O
antiviral 173 182 636 645 B-allergy_name
drugs 183 188 646 651 I-allergy_name
, 188 189 651 652 O
or 190 192 653 655 O
intolerance 193 204 656 667 O
to 205 207 668 670 O
hydration 208 217 671 680 O
due 218 221 681 684 O
to 222 224 685 687 O
preexisting 225 236 688 699 O
pulmonary 237 246 700 709 B-chronic_disease
or 247 249 710 712 O
cardiac 250 257 713 720 B-chronic_disease
impairment 258 268 721 731 I-chronic_disease

Must 0 4 732 736 O
not 5 8 737 740 O
have 9 13 741 745 O
acute 14 19 746 751 O
active 20 26 752 758 B-chronic_disease
infection 27 36 759 768 I-chronic_disease
requiring 37 46 769 778 O
treatment 47 56 779 788 B-treatment
( 57 58 789 790 O
systemic 58 66 790 798 B-treatment
antibiotics 67 78 799 810 I-treatment
, 78 79 810 811 O
antivirals 80 90 812 822 B-treatment
, 90 91 822 823 O
or 92 94 824 826 O
antifungals 95 106 827 838 B-treatment
) 106 107 838 839 O
within 108 114 840 846 O
14 115 117 847 849 B-upper_bound
days 118 122 850 854 I-upper_bound
prior 123 128 855 860 I-upper_bound
to 129 131 861 863 O
enrollment 132 142 864 874 O

Must 0 4 875 879 O
not 5 8 880 883 O
have 9 13 884 888 O
any 14 17 889 892 O
evidence 18 26 893 901 O
of 27 29 902 904 O
other 30 35 905 910 O
clinically 36 46 911 921 O
active 47 53 922 928 O
cancer 54 60 929 935 B-cancer
and 61 64 936 939 O
have 65 69 940 944 O
no 70 72 945 947 O
history 73 80 948 955 O
of 81 83 956 958 O
prior 84 89 959 964 O
malignancy 90 100 965 975 B-cancer
within 101 107 976 982 O
the 108 111 983 986 O
past 112 116 987 991 B-upper_bound
3 117 118 992 993 I-upper_bound
years 119 124 994 999 I-upper_bound

Must 0 4 1000 1004 O
not 5 8 1005 1008 O
have 9 13 1009 1013 O
any 14 17 1014 1017 O
known 18 23 1018 1023 O
history 24 31 1024 1031 O
of 32 34 1032 1034 O
allergy 35 42 1035 1042 O
to 43 45 1043 1045 O
Captisol 46 54 1046 1054 B-allergy_name
® 54 55 1054 1055 I-allergy_name
( 56 57 1056 1057 O
a 57 58 1057 1058 O
cyclodextrin 59 71 1059 1071 B-allergy_name
derivative 72 82 1072 1082 O
used 83 87 1083 1087 O
to 88 90 1088 1090 O
solubilize 91 101 1091 1101 O
carfilzomib 102 113 1102 1113 B-allergy_name
) 113 114 1113 1114 O

Must 0 4 1115 1119 O
not 5 8 1120 1123 O
have 9 13 1124 1128 O
any 14 17 1129 1132 O
known 18 23 1133 1138 O
human 24 29 1139 1144 B-chronic_disease
immunodeficiency 30 46 1145 1161 I-chronic_disease
virus 47 52 1162 1167 I-chronic_disease
infection 53 62 1168 1177 I-chronic_disease

Must 0 4 1178 1182 O
not 5 8 1183 1186 O
have 9 13 1187 1191 O
any 14 17 1192 1195 O
other 18 23 1196 1201 O
clinically 24 34 1202 1212 O
significant 35 46 1213 1224 O
medical 47 54 1225 1232 B-chronic_disease
disease 55 62 1233 1240 I-chronic_disease
or 63 65 1241 1243 O
condition 66 75 1244 1253 O
that 76 80 1254 1258 O
, 80 81 1258 1259 O
in 82 84 1260 1262 O
the 85 88 1263 1266 O
Investigator 89 101 1267 1279 O
's 101 103 1279 1281 O
opinion 104 111 1282 1289 O
, 111 112 1289 1290 O
may 113 116 1291 1294 O
interfere 117 126 1295 1304 O
with 127 131 1305 1309 O
protocol 132 140 1310 1318 O
adherence 141 150 1319 1328 O
or 151 153 1329 1331 O
a 154 155 1332 1333 O
subject 156 163 1334 1341 O
's 163 165 1341 1343 O
ability 166 173 1344 1351 O
to 174 176 1352 1354 O
give 177 181 1355 1359 O
informed 182 190 1360 1368 O
consent 191 198 1369 1376 O

Must 0 4 1377 1381 O
not 5 8 1382 1385 O
have 9 13 1386 1390 O
any 14 17 1391 1394 O
significant 18 29 1395 1406 O
neuropathy 30 40 1407 1417 B-chronic_disease
( 41 42 1418 1419 O
Grades 42 48 1419 1425 B-lower_bound
3 49 50 1426 1427 I-lower_bound
- 50 51 1427 1428 O
4 51 52 1428 1429 B-upper_bound
, 52 53 1429 1430 O
or 54 56 1431 1433 O
Grade 57 62 1434 1439 O
2 63 64 1440 1441 O
with 65 69 1442 1446 O
pain 70 74 1447 1451 O
) 74 75 1451 1452 O
within 76 82 1453 1459 O
14 83 85 1460 1462 B-upper_bound
days 86 90 1463 1467 I-upper_bound
prior 91 96 1468 1473 I-upper_bound
to 97 99 1474 1476 O
enrollment 100 110 1477 1487 O

Must 0 4 1488 1492 O
not 5 8 1493 1496 O
have 9 13 1497 1501 O
any 14 17 1502 1505 O
uncontrolled 18 30 1506 1518 O
hypertension 31 43 1519 1531 B-chronic_disease
or 44 46 1532 1534 O
uncontrolled 47 59 1535 1547 O
diabetes 60 68 1548 1556 B-chronic_disease
within 69 75 1557 1563 O
14 76 78 1564 1566 B-upper_bound
days 79 83 1567 1571 I-upper_bound
prior 84 89 1572 1577 I-upper_bound
to 90 92 1578 1580 O
enrollment 93 103 1581 1591 O

Must 0 4 1592 1596 O
not 5 8 1597 1600 O
have 9 13 1601 1605 O
had 14 17 1606 1609 O
any 18 21 1610 1613 O
unstable 22 30 1614 1622 B-chronic_disease
angina 31 37 1623 1629 I-chronic_disease
or 38 40 1630 1632 O
myocardial 41 51 1633 1643 B-chronic_disease
infarction 52 62 1644 1654 I-chronic_disease
within 63 69 1655 1661 O
4 70 71 1662 1663 B-upper_bound
months 72 78 1664 1670 I-upper_bound
prior 79 84 1671 1676 I-upper_bound
to 85 87 1677 1679 O
enrollment 88 98 1680 1690 O
, 98 99 1690 1691 O
NYHA 100 104 1692 1696 B-clinical_variable
Class 105 110 1697 1702 B-lower_bound
III 111 114 1703 1706 I-lower_bound
or 115 117 1707 1709 O
IV 118 120 1710 1712 B-upper_bound
heart 121 126 1713 1718 B-chronic_disease
failure 127 134 1719 1726 I-chronic_disease
, 134 135 1726 1727 O
uncontrolled 136 148 1728 1740 B-chronic_disease
angina 149 155 1741 1747 I-chronic_disease
, 155 156 1747 1748 O
history 157 164 1749 1756 O
of 165 167 1757 1759 O
severe 168 174 1760 1766 O
coronary 175 183 1767 1775 B-chronic_disease
artery 184 190 1776 1782 I-chronic_disease
disease 191 198 1783 1790 I-chronic_disease
, 198 199 1790 1791 O
severe 200 206 1792 1798 O
uncontrolled 207 219 1799 1811 O
ventricular 220 231 1812 1823 B-chronic_disease
arrhythmias 232 243 1824 1835 I-chronic_disease
, 243 244 1835 1836 O
sick 245 249 1837 1841 B-chronic_disease
sinus 250 255 1842 1847 I-chronic_disease
syndrome 256 264 1848 1856 I-chronic_disease
, 264 265 1856 1857 O
or 266 268 1858 1860 O
electrocardiographic 269 289 1861 1881 B-treatment
evidence 290 298 1882 1890 O
of 299 301 1891 1893 O
acute 302 307 1894 1899 O
ischemia 308 316 1900 1908 B-chronic_disease
or 317 319 1909 1911 O
Grade 320 325 1912 1917 O
3 326 327 1918 1919 O
conduction 328 338 1920 1930 O
system 339 345 1931 1937 O
abnormalities 346 359 1938 1951 O
unless 360 366 1952 1958 O
subject 367 374 1959 1966 O
has 375 378 1967 1970 O
a 379 380 1971 1972 O
pacemaker 381 390 1973 1982 O

Must 0 4 1983 1987 O
not 5 8 1988 1991 O
have 9 13 1992 1996 O
known 14 19 1997 2002 O
active 20 26 2003 2009 O
or 27 29 2010 2012 O
clinically 30 40 2013 2023 O
significant 41 52 2024 2035 O
hepatitis 53 62 2036 2045 B-chronic_disease
A 63 64 2046 2047 I-chronic_disease
, 64 65 2047 2048 I-chronic_disease
B 66 67 2049 2050 I-chronic_disease
or 68 70 2051 2053 I-chronic_disease
C 71 72 2054 2055 I-chronic_disease
infection 73 82 2056 2065 I-chronic_disease

Must 0 4 2066 2070 O
not 5 8 2071 2074 O
have 9 13 2075 2079 O
leptomeningeal 14 28 2080 2094 B-cancer
metastases 29 39 2095 2105 I-cancer

No 0 2 2106 2108 O
prior 3 8 2109 2114 B-treatment
irinotecan 9 19 2115 2125 I-treatment
or 20 22 2126 2128 O
carfilzomib 23 34 2129 2140 B-treatment

Patients 0 8 2141 2149 O
may 9 12 2150 2153 O
have 13 17 2154 2158 O
received 18 26 2159 2167 O
previous 27 35 2168 2176 O
radiation 36 45 2177 2186 B-treatment
therapy 46 53 2187 2194 I-treatment
, 53 54 2194 2195 O
but 55 58 2196 2199 O
it 59 61 2200 2202 O
must 62 66 2203 2207 O
have 67 71 2208 2212 O
been 72 76 2213 2217 O
completed 77 86 2218 2227 O
at 87 89 2228 2230 O
least 90 95 2231 2236 O
21 96 98 2237 2239 B-lower_bound
days 99 103 2240 2244 I-lower_bound
prior 104 109 2245 2250 I-lower_bound
to 110 112 2251 2253 O
enrollment 113 123 2254 2264 O
and 124 127 2265 2268 O
the 128 131 2269 2272 O
patient 132 139 2273 2280 O
should 140 146 2281 2287 O
have 147 151 2288 2292 O
recovered 152 161 2293 2302 O
from 162 166 2303 2307 O
all 167 170 2308 2311 O
associated 171 181 2312 2322 O
toxicities 182 192 2323 2333 O

Patients 0 8 2334 2342 O
may 9 12 2343 2346 O
have 13 17 2347 2351 O
received 18 26 2352 2360 O
prior 27 32 2361 2366 B-treatment
surgery 33 40 2367 2374 I-treatment
provided 41 49 2375 2383 O
that 50 54 2384 2388 O
at 55 57 2389 2391 O
least 58 63 2392 2397 O
28 64 66 2398 2400 B-lower_bound
days 67 71 2401 2405 I-lower_bound
have 72 76 2406 2410 O
elapsed 77 84 2411 2418 O
since 85 90 2419 2424 O
major 91 96 2425 2430 B-treatment
surgery 97 104 2431 2438 I-treatment
( 105 106 2439 2440 O
thoracic 106 114 2440 2448 B-treatment
or 115 117 2449 2451 O
other 118 123 2452 2457 O
major 124 129 2458 2463 B-treatment
surgeries 130 139 2464 2473 I-treatment
) 139 140 2473 2474 O
and 141 144 2475 2478 O
the 145 148 2479 2482 O
patient 149 156 2483 2490 O
has 157 160 2491 2494 O
recovered 161 170 2495 2504 O
from 171 175 2505 2509 O
all 176 179 2510 2513 O
associated 180 190 2514 2524 O
toxicities 191 201 2525 2535 O

Patients 0 8 2536 2544 O
must 9 13 2545 2549 O
be 14 16 2550 2552 O
18 17 19 2553 2555 B-lower_bound
years 20 25 2556 2561 I-lower_bound
of 26 28 2562 2564 O
age 29 32 2565 2568 B-age
or 33 35 2569 2571 O
older 36 41 2572 2577 O

Patients 0 8 2578 2586 O
must 9 13 2587 2591 O
have 14 18 2592 2596 O
a 19 20 2597 2598 O
serum 21 26 2599 2604 B-clinical_variable
creatinine 27 37 2605 2615 I-clinical_variable
≤ 38 39 2616 2617 O
the 40 43 2618 2621 O
institutional 44 57 2622 2635 O
upper 58 63 2636 2641 O
limit 64 69 2642 2647 O
of 70 72 2648 2650 O
normal 73 79 2651 2657 O
OR 80 82 2658 2660 O
a 83 84 2661 2662 O
creatinine 85 95 2663 2673 B-clinical_variable
clearance 96 105 2674 2683 I-clinical_variable
≥ 106 107 2684 2685 O
60 108 110 2686 2688 B-lower_bound
cc 111 113 2689 2691 I-lower_bound
/ 113 114 2691 2692 I-lower_bound
min 114 117 2692 2695 I-lower_bound
, 117 118 2695 2696 O
measured 119 127 2697 2705 O
or 128 130 2706 2708 O
calculated 131 141 2709 2719 O
( 142 143 2720 2721 O
Cockcroft 143 152 2721 2730 B-clinical_variable
- 152 153 2730 2731 I-clinical_variable
Gault 153 158 2731 2736 I-clinical_variable
formula 159 166 2737 2744 I-clinical_variable
) 166 167 2744 2745 O
, 167 168 2745 2746 O
obtained 169 177 2747 2755 O
within 178 184 2756 2762 O
14 185 187 2763 2765 B-upper_bound
days 188 192 2766 2770 I-upper_bound
prior 193 198 2771 2776 O
to 199 201 2777 2779 O
registration 202 214 2780 2792 O

Patients 0 8 2793 2801 O
must 9 13 2802 2806 O
have 14 18 2807 2811 O
adequate 19 27 2812 2820 O
hepatic 28 35 2821 2828 O
function 36 44 2829 2837 O
as 45 47 2838 2840 O
documented 48 58 2841 2851 O
by 59 61 2852 2854 O
a 62 63 2855 2856 O
bilirubin 64 73 2857 2866 B-clinical_variable
≤ 74 75 2867 2868 O
2 76 77 2869 2870 B-upper_bound
x 78 79 2871 2872 I-upper_bound
the 80 83 2873 2876 I-upper_bound
institutional 84 97 2877 2890 I-upper_bound
upper 98 103 2891 2896 I-upper_bound
limit 104 109 2897 2902 I-upper_bound
of 110 112 2903 2905 I-upper_bound
normal 113 119 2906 2912 I-upper_bound
, 119 120 2912 2913 O
an 121 123 2914 2916 O
alkaline 124 132 2917 2925 B-clinical_variable
phosphatase 133 144 2926 2937 I-clinical_variable
≤ 145 146 2938 2939 O
2 147 148 2940 2941 O
x 149 150 2942 2943 O
the 151 154 2944 2947 O
institutional 155 168 2948 2961 O
upper 169 174 2962 2967 O
limit 175 180 2968 2973 O
of 181 183 2974 2976 O
normal 184 190 2977 2983 O
, 190 191 2983 2984 O
and 192 195 2985 2988 O
an 196 198 2989 2991 O
SGOT 199 203 2992 2996 B-clinical_variable
and 204 207 2997 3000 O
SGPT 208 212 3001 3005 B-clinical_variable
≤ 213 214 3006 3007 O
2 215 216 3008 3009 O
x 217 218 3010 3011 O
the 219 222 3012 3015 O
institutional 223 236 3016 3029 O
upper 237 242 3030 3035 O
limit 243 248 3036 3041 O
of 249 251 3042 3044 O
normal 252 258 3045 3051 O
all 259 262 3052 3055 O
obtained 263 271 3056 3064 O
within 272 278 3065 3071 O
14 279 281 3072 3074 B-upper_bound
days 282 286 3075 3079 I-upper_bound
prior 287 292 3080 3085 I-upper_bound
to 293 295 3086 3088 O
enrollment 296 306 3089 3099 O

Patients 0 8 3100 3108 O
must 9 13 3109 3113 O
have 14 18 3114 3118 O
an 19 21 3119 3121 O
ANC 22 25 3122 3125 B-clinical_variable
≥ 26 27 3126 3127 O
1,500 28 33 3128 3133 B-lower_bound
/ 33 34 3133 3134 I-lower_bound
μl 34 36 3134 3136 I-lower_bound
and 37 40 3137 3140 O
a 41 42 3141 3142 O
platelet 43 51 3143 3151 B-clinical_variable
count 52 57 3152 3157 I-clinical_variable
≥ 58 59 3158 3159 O
100,000 60 67 3160 3167 B-lower_bound
/ 67 68 3167 3168 I-lower_bound
μl 68 70 3168 3170 I-lower_bound
obtained 71 79 3171 3179 O
within 80 86 3180 3186 O
14 87 89 3187 3189 B-upper_bound
days 90 94 3190 3194 I-upper_bound
prior 95 100 3195 3200 I-upper_bound
to 101 103 3201 3203 O
registration 104 116 3204 3216 O

Patients 0 8 3217 3225 O
must 9 13 3226 3230 O
have 14 18 3231 3235 O
disease 19 26 3236 3243 O
outside 27 34 3244 3251 O
of 35 37 3252 3254 O
the 38 41 3255 3258 O
previous 42 50 3259 3267 B-treatment
surgical 51 59 3268 3276 I-treatment
resection 60 69 3277 3286 I-treatment
area 70 74 3287 3291 O
or 75 77 3292 3294 O
a 78 79 3295 3296 O
new 80 83 3297 3300 O
lesion 84 90 3301 3307 O
must 91 95 3308 3312 O
be 96 98 3313 3315 O
present 99 106 3316 3323 O

Patients 0 8 3324 3332 O
must 9 13 3333 3337 O
have 14 18 3338 3342 O
measurable 19 29 3343 3353 O
disease 30 37 3354 3361 O
per 38 41 3362 3365 O
RECIST 42 48 3366 3372 O
criteria 49 57 3373 3381 O
1.1 58 61 3382 3385 O
performed 62 71 3386 3395 O
within 72 78 3396 3402 O
28 79 81 3403 3405 B-upper_bound
days 82 86 3406 3410 I-upper_bound
prior 87 92 3411 3416 I-upper_bound
to 93 95 3417 3419 O
enrollment 96 106 3420 3430 O

Patients 0 8 3431 3439 O
must 9 13 3440 3444 O
not 14 17 3445 3448 B-pregnancy
be 18 20 3449 3451 I-pregnancy
pregnant 21 29 3452 3460 I-pregnancy
or 30 32 3461 3463 O
lactating 33 42 3464 3473 O
females 43 50 3474 3481 B-gender

Patients 0 8 3482 3490 O
must 9 13 3491 3495 O
not 14 17 3496 3499 B-pregnancy
be 18 20 3500 3502 I-pregnancy
pregnant 21 29 3503 3511 I-pregnancy
or 30 32 3512 3514 O
nursing 33 40 3515 3522 O

Patients 0 8 3523 3531 O
who 9 12 3532 3535 O
have 13 17 3536 3540 O
clinical 18 26 3541 3549 O
evidence 27 35 3550 3558 O
of 36 38 3559 3561 O
recurrent 39 48 3562 3571 O
small 49 54 3572 3577 B-cancer
cell 55 59 3578 3582 I-cancer
lung 60 64 3583 3587 I-cancer
cancer 65 71 3588 3594 I-cancer
do 72 74 3595 3597 O
not 75 78 3598 3601 O
require 79 86 3602 3609 O
a 87 88 3610 3611 O
confirmatory 89 101 3612 3624 O
biopsy 102 108 3625 3631 B-treatment
to 109 111 3632 3634 O
be 112 114 3635 3637 O
eligible 115 123 3638 3646 O
for 124 127 3647 3650 O
this 128 132 3651 3655 O
trial 133 138 3656 3661 O

Patients 0 8 3662 3670 O
who 9 12 3671 3674 O
progressed 13 23 3675 3685 O
during 24 30 3686 3692 O
or 31 33 3693 3695 O
within 34 40 3696 3702 O
one 41 44 3703 3706 B-upper_bound
month 45 50 3707 3712 I-upper_bound
of 51 53 3713 3715 O
completing 54 64 3716 3726 O
platinum 65 73 3727 3735 B-treatment
- 73 74 3735 3736 I-treatment
based 74 79 3736 3741 I-treatment
chemotherapy 80 92 3742 3754 I-treatment

Patients 0 8 3755 3763 O
who 9 12 3764 3767 O
received 13 21 3768 3776 O
primary 22 29 3777 3784 O
curative 30 38 3785 3793 O
chemoradiation 39 53 3794 3808 B-treatment
therapy 54 61 3809 3816 I-treatment
for 62 65 3817 3820 O
limited 66 73 3821 3828 O
disease 74 81 3829 3836 O
, 81 82 3836 3837 O
but 83 86 3838 3841 O
who 87 90 3842 3845 O
recur 91 96 3846 3851 O
within 97 103 3852 3858 O
the 104 107 3859 3862 O
primary 108 115 3863 3870 O
tumor 116 121 3871 3876 B-cancer
site 122 126 3877 3881 O
, 126 127 3881 3882 O
previously 128 138 3883 3893 O
radiated 139 147 3894 3902 O
field 148 153 3903 3908 O
or 154 156 3909 3911 O
with 157 161 3912 3916 O
distant 162 169 3917 3924 B-cancer
metastases 170 180 3925 3935 I-cancer

Patients 0 8 3936 3944 O
with 9 13 3945 3949 O
known 14 19 3950 3955 O
brain 20 25 3956 3961 B-cancer
metastases 26 36 3962 3972 I-cancer
are 37 40 3973 3976 O
eligible 41 49 3977 3985 O
only 50 54 3986 3990 O
if 55 57 3991 3993 O
he 58 60 3994 3996 O
/ 60 61 3996 3997 O
she 61 64 3997 4000 O
has 65 68 4001 4004 O
been 69 73 4005 4009 O
treated 74 81 4010 4017 O
for 82 85 4018 4021 O
brain 86 91 4022 4027 B-cancer
metastasis 92 102 4028 4038 I-cancer
, 102 103 4038 4039 O
are 104 107 4040 4043 O
asymptomatic 108 120 4044 4056 O
after 121 126 4057 4062 O
treatment 127 136 4063 4072 B-treatment
, 136 137 4072 4073 O
have 138 142 4074 4078 O
a 143 144 4079 4080 O
stable 145 151 4081 4087 O
CT 152 154 4088 4090 B-treatment
or 155 157 4091 4093 O
MRI 158 161 4094 4097 B-treatment
of 162 164 4098 4100 I-treatment
the 165 168 4101 4104 I-treatment
brain 169 174 4105 4110 I-treatment
within 175 181 4111 4117 O
28 182 184 4118 4120 B-upper_bound
days 185 189 4121 4125 I-upper_bound
of 190 192 4126 4128 O
enrollment 193 203 4129 4139 O
and 204 207 4140 4143 O
are 208 211 4144 4147 O
not 212 215 4148 4151 O
receiving 216 225 4152 4161 O
corticosteroid 226 240 4162 4176 B-treatment
therapy 241 248 4177 4184 I-treatment
to 249 251 4185 4187 O
control 252 259 4188 4195 O
symptoms 260 268 4196 4204 O
from 269 273 4205 4209 O
brain 274 279 4210 4215 O
metastasis 280 290 4216 4226 O

Phase 0 5 4227 4232 B-clinical_variable
II 6 8 4233 4235 I-clinical_variable
: 8 9 4235 4236 O
0 10 11 4237 4238 B-lower_bound
, 11 12 4238 4239 O
1 13 14 4240 4241 O
or 15 17 4242 4244 O
2 18 19 4245 4246 B-upper_bound

Phase 0 5 4247 4252 O
II 6 8 4253 4255 O
: 8 9 4255 4256 O
extensive 10 19 4257 4266 O
stage 20 25 4267 4272 O
small 26 31 4273 4278 B-cancer
cell 32 36 4279 4283 I-cancer
lung 37 41 4284 4288 I-cancer
cancer 42 48 4289 4295 I-cancer
with 49 53 4296 4300 O
progression 54 65 4301 4312 O
or 66 68 4313 4315 O
recurrence 69 79 4316 4326 O
after 80 85 4327 4332 O
exactly 86 93 4333 4340 O
one 94 97 4341 4344 O
platinum 98 106 4345 4353 B-treatment
- 106 107 4353 4354 I-treatment
containing 107 117 4354 4364 I-treatment
regimen 118 125 4365 4372 I-treatment

Phase 0 5 4373 4378 B-clinical_variable
Ib 6 8 4379 4381 I-clinical_variable
: 8 9 4381 4382 O
0 10 11 4383 4384 B-lower_bound
or 12 14 4385 4387 O
1 15 16 4388 4389 B-upper_bound

Prior 0 5 4390 4395 B-treatment
irinotecan 6 16 4396 4406 I-treatment

Subjects 0 8 4407 4415 O
that 9 13 4416 4420 O
progressed 14 24 4421 4431 O
during 25 31 4432 4438 O
or 32 34 4439 4441 O
within 35 41 4442 4448 O
one 42 45 4449 4452 B-upper_bound
month 46 51 4453 4458 I-upper_bound
of 52 54 4459 4461 O
completion 55 65 4462 4472 O
of 66 68 4473 4475 O
first 69 74 4476 4481 B-treatment
- 74 75 4481 4482 I-treatment
line 75 79 4482 4486 I-treatment
platinum 80 88 4487 4495 I-treatment
- 88 89 4495 4496 I-treatment
based 89 94 4496 4501 I-treatment
chemotherapy 95 107 4502 4514 I-treatment

Women 0 5 4515 4520 B-gender
/ 5 6 4520 4521 I-gender
men 6 9 4521 4524 I-gender
of 10 12 4525 4527 O
reproductive 13 25 4528 4540 O
potential 26 35 4541 4550 O
must 36 40 4551 4555 O
have 41 45 4556 4560 O
agreed 46 52 4561 4567 B-contraception_consent
to 53 55 4568 4570 I-contraception_consent
use 56 59 4571 4574 I-contraception_consent
an 60 62 4575 4577 I-contraception_consent
effective 63 72 4578 4587 I-contraception_consent
contraceptive 73 86 4588 4601 I-contraception_consent
method 87 93 4602 4608 I-contraception_consent
( 94 95 4609 4610 O
hormonal 95 103 4610 4618 B-contraception_consent
or 104 106 4619 4621 O
barrier 107 114 4622 4629 B-contraception_consent
method 115 121 4630 4636 I-contraception_consent
of 122 124 4637 4639 I-contraception_consent
birth 125 130 4640 4645 I-contraception_consent
control 131 138 4646 4653 I-contraception_consent

have 0 4 4654 4658 O
histologically 5 19 4659 4673 O
or 20 22 4674 4676 O
cytologically 23 36 4677 4690 O
- 36 37 4690 4691 O
confirmed 37 46 4691 4700 O
diagnosis 47 56 4701 4710 O
of 57 59 4711 4713 O
progressive 60 71 4714 4725 O
or 72 74 4726 4728 O
recurrent 75 84 4729 4738 O
malignancy 85 95 4739 4749 B-cancer

